Condor

Condor Software is a San Diego-based software company that provides what it calls a Financial Intelligence Platform for life sciences. The platform consolidates clinical, operational, and financial data into a single data model so that accounting, FP&A, clinical operations, and internal audit teams at biopharma companies can track and forecast R&D and clinical trial spend in real time. It targets workflows that the company says are typically handled in spreadsheets and disconnected systems: accrual calculation, CRO invoice reconciliation, change-order tracking, month-end close, and board-level forecasting.

The product is organized into three core modules. Connect integrates ERP, EDC, CTMS, IRT and vendor systems using what the company describes as SMART mapping and AI-enabled data ingestion. Compass provides advanced analytics, dashboards, cost forecasting, scenario modeling, and risk surfacing across a program portfolio. Copilot is an AI assistant that automates accruals, variance detection, reconciliations, and month-end close tasks. Supporting platform capabilities include granular access controls, audit trails and approvals framed as "compliance by design," codeless configuration, and enterprise security features such as encryption, MFA and SSO. Condor states it is SOC 1 Type 2 and SOC 2 Type 2 compliant and positions the platform for SOX/404(b) and IPO readiness.

Condor markets to emerging and mid-sized biopharma, enterprise biopharma, medtech, and CROs and partners, and lists named customers including Acadia Pharmaceuticals, Alumis Therapeutics, BridgeBio Pharma, and Madrigal Pharmaceuticals. As of its March 2026 Series A announcement, the company said it manages over $19 billion in R&D spend.

Founding story

Founder and CEO Jennifer (Jen) Kyle spent years in pharma, where she built accounting workflows used by the pharmaceutical industry to manage clinical trial finances and observed the impact of clinical trials, including on her own family. She assembled a group of industry leaders to build Condor as an enterprise-grade financial cloud intended to replace fragmented processes and disconnected systems in biopharma R&D finance.

Business model

Condor sells enterprise SaaS to life sciences organizations, with a platform offering (Connect, Compass, Copilot) plus customer success and professional services; its site lists a pricing page, a referral program, and partner and CRO channels.

Software platform sold to biopharma finance and clinical operations organizations, complemented by professional services and customer success offerings; specific pricing terms are not disclosed in the sources.

Traction

Condor reports managing over $19 billion in R&D spend and serving accounting, FP&A and clinical operations teams at emerging biotechs and larger biopharma organizations, including Acadia Pharmaceuticals, Alumis Therapeutics, BridgeBio Pharma, and Madrigal Pharmaceuticals. Customers report over 90% forecast accuracy, 70% faster month-end close, and roughly 30% average budget savings; one customer cited scaling from 2-3 studies to 15 without adding headcount, and Alumis expects a 30-40% operating efficiency gain.

Latest developments

In March 2026 Condor announced a $24 million Series A led by Insight Partners (with Felicis, 645 Ventures, Pamir Ventures, SNR Ventures, Prebys Ventures and Bramalea Partners), taking total funding to $36 million, to be used for platform expansion, enterprise capabilities for large pharmaceutical customers, and hiring in engineering, product, design, sales and customer success. The company also introduced an Advanced Analytics and Dynamic Scenario Suite.